(Q45889157)

17 December 2017

title

Enhanced transduction of mouse salivary glands with AAV5-based vectors (English)

1 reference

17 December 2017

author

Seiichi Yamano

4

1 reference

17 December 2017

author name string

Katano H

1

1 reference

17 December 2017

Kok MR

2

1 reference

17 December 2017

Cotrim AP

3

1 reference

17 December 2017

Schmidt M

5

1 reference

17 December 2017

Afione S

6

1 reference

17 December 2017

Baum BJ

7

1 reference

17 December 2017

Chiorini JA

8

1 reference

17 December 2017

publication date

1 April 2006

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

13

1 reference

17 December 2017

issue

7

1 reference

17 December 2017

page(s)

594-601

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302691

exact match

0 references

cites work

Advances in vector-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Genomic integration and gene expression by a modified adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Adenoassociated virus-mediated transfer of a functional water channel into salivary epithelial cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Rapamycin control of exocrine protein levels in saliva after adenoviral vector-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Identification of PDGFR as a receptor for AAV-5 transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Recombinant adeno-associated virus serotype 2 vectors mediate stable interleukin 10 secretion from salivary glands into the bloodstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Distribution and toxicity resulting from adenoviral vector administration to a single salivary gland in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Immune responses to adenovirus and adeno-associated virus in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Salivary mucins in oral mucosal defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Repetitive adenovirus administration to the parotid gland: role of immunological barriers and induction of oral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Salivary glands: novel target sites for gene therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Clades of Adeno-associated viruses are widely disseminated in human tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Adenoviral-mediated gene transfer to mouse salivary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

inferred from DOI database lookup

7 January 2021

based on heuristic

Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302691

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302691

1 reference

17 December 2017

Dimensions Publication ID

1027239070

0 references

1 reference

17 December 2017